Effect of protein, fat, carbohydrate and fibre on gastrointestinal peptide release in humans

Regulatory Peptides

Volumn 149, Issue 1-3, 2008, Pages 70-78

  Karhunen, L J ^a   Juvonen, K R ^a   Huotari, A ^a   Purhonen, A K ^a   Herzig, K H ^a,b  

^a UNIVERSITY OF EASTERN FINLAND   (Finland)

^b KUOPIO UNIVERSITY HOSPITAL   (Finland)

Author keywords

Fibre; Humans; Intestine; Macronutrients; Peptide release; Satiety

Indexed keywords

AMYLIN; CARBOHYDRATE; CHOLECYSTOKININ; FAT; GASTRIC INHIBITORY POLYPEPTIDE; GASTROINTESTINAL POLYPEPTIDE; GHRELIN; GLUCAGON LIKE PEPTIDE 1; INSULIN; PANCREAS POLYPEPTIDE; PEPTIDE YY;

ADIPOSE TISSUE; ARTICLE; HUMAN; INSULIN RELEASE; MACRONUTRIENT; MECHANICAL STIMULATION; NUTRIENT; PRIORITY JOURNAL; PROTEIN SECRETION; SATIETY; STOMACH EMPTYING;

AMYLOID; CARBOHYDRATES; CHOLECYSTOKININ; DIETARY FATS; DIETARY FIBER; GASTRIC INHIBITORY POLYPEPTIDE; GASTROINTESTINAL TRACT; GHRELIN; GLUCAGON-LIKE PEPTIDE 1; HUMANS; INSULIN; NEUROPEPTIDE Y; PANCREATIC POLYPEPTIDE; PEPTIDES; PROTEINS;

EID: 48849105732     PISSN: 01670115     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.regpep.2007.10.008     Document Type: Article

References (187)

1. Havel P.J. Peripheral signals conveying metabolic information to the brain: short-term and long-term regulation of food intake and energy homeostasis. Exp Biol Med (Maywood) 226 (2001) 963-977
2. Oesch S., Ruegg C., Fischer B., Degen L., and Beglinger C. Effect of gastric distension prior to eating on food intake and feelings of satiety in humans. Physiol Behav 87 (2006) 903-910
3. Cummings D.E., and Overduin J. Gastrointestinal regulation of food intake. J Clin Invest 117 (2007) 13-23
4. Berthoud H.R. Multiple neural systems controlling food intake and body weight. Neurosci Biobehav Rev 26 (2002) 393-428
5. Saunders N.R., Habgood M.D., and Dziegielewska K.M. Barrier mechanisms in the brain, I. Adult brain. Clin Exp Pharmacol Physiol 26 (1999) 11-19
6. Fry M., and Ferguson A.V. The sensory circumventricular organs: Brain targets for circulating signals controlling ingestive behavior. Physiol Behav 91 (2007) 413-423
7. Kojima M., Hosoda H., Date Y., Nakazato M., Matsuo H., and Kangawa K. Ghrelin is a growth-hormone-releasing acylated peptide from stomach. Nature 402 (1999) 656-660
8. Ariyasu H., Takaya K., Tagami T., Ogawa Y., Hosoda K., Akamizu T., Suda M., Koh T., Natsui K., Toyooka S., Shirakami G., Usui T., Shimatsu A., Doi K., Hosoda H., Kojima M., Kangawa K., and Nakao K. Stomach is a major source of circulating ghrelin, and feeding state determines plasma ghrelin-like immunoreactivity levels in humans. J Clin Endocrinol Metab 86 (2001) 4753-4758
9. Gnanapavan S., Kola B., Bustin S.A., Morris D.G., McGee P., Fairclough P., Bhattacharya S., Carpenter R., Grossman A.B., and Korbonits M. The tissue distribution of the mRNA of ghrelin and subtypes of its receptor, GHS-R, in humans. J Clin Endocrinol Metab 87 (2002) 2988
10. Hosoda H., Kojima M., Matsuo H., and Kangawa K. Ghrelin and des-acyl ghrelin: two major forms of rat ghrelin peptide in gastrointestinal tissue. Biochem Biophys Res Commun 279 (2000) 909-913
11. Cummings D.E. Ghrelin and the short- and long-term regulation of appetite and body weight. Physiol Behav 89 (2006) 71-84
12. Wren A.M., Seal L.J., Cohen M.A., Brynes A.E., Frost G.S., Murphy K.G., Dhillo W.S., Ghatei M.A., and Bloom S.R. Ghrelin enhances appetite and increases food intake in humans. J Clin Endocrinol Metab 86 (2001) 5992
13. Druce M.R., Wren A.M., Park A.J., Milton J.E., Patterson M., Frost G., Ghatei M.A., Small C., and Bloom S.R. Ghrelin increases food intake in obese as well as lean subjects. Int J Obes (Lond) 29 (2005) 1130-1136
14. Druce M.R., Neary N.M., Small C.J., Milton J., Monteiro M., Patterson M., Ghatei M.A., and Bloom S.R. Subcutaneous administration of ghrelin stimulates energy intake in healthy lean human volunteers. Int J Obes (Lond) 30 (2006) 293-296
15. Drazen D.L., Vahl T.P., D'Alessio D.A., Seeley R.J., and Woods S.C. Effects of a fixed meal pattern on ghrelin secretion: evidence for a learned response independent of nutrient status. Endocrinology 147 (2006) 23-30
16. Cummings D.E., Weigle D.S., Frayo R.S., Breen P.A., Ma M.K., Dellinger E.P., and Purnell J.Q. Plasma ghrelin levels after diet-induced weight loss or gastric bypass surgery. N Engl J Med 346 (2002) 1623-1630
17. Callahan H.S., Cummings D.E., Pepe M.S., Breen P.A., Matthys C.C., and Weigle D.S. Postprandial suppression of plasma ghrelin level is proportional to ingested caloric load but does not predict intermeal interval in humans. J Clin Endocrinol Metab 89 (2004) 1319-1324
18. Little T.J., Doran S., Meyer J.H., Smout A.J.P.M., O'Donovan D.G., Wu K.L., Jones K.L., Wishart J., Rayner C.K., Horowitz M., and Bisset C.F. The release of GLP-1 and ghrelin, but not GIP and CCK, by glucose is dependent upon the length of small intestine exposed. Am J Physiol Endocrinol Metab 291 (2006) E647-E655
19. Shiiya T., Nakazato M., Mizuta M., Date Y., Mondal M.S., Tanaka M., Nozoe S.I., Hosoda H., Kangawa K., and Matsukura S. Plasma ghrelin levels in lean and obese humans and the effect of glucose on ghrelin secretion. J Clin Endocrinol Metab 87 (2002) 240-244
20. Blom W.A.M., Stafleu A., de Graaf C., Kok F.J., Schaafsma G., and Hendriks H.F.J. Ghrelin response to carbohydrate-enriched breakfast is related to insulin. Am J Clin Nutr 81 (2005) 367-375
21. Monteleone P., Bencivenga R., Longobardi N., Serritella C., and Maj M. Differential responses of circulating ghrelin to high-fat or high-carbohydrate meal in healthy women. J Clin Endocrinol Metab 88 (2003) 5510-5514
22. Tannaous dit El Khoury D., Obeid O., Azar S.T., and Hwalla N. Variations in postprandial ghrelin status following ingestion of high-carbohydrate, high-fat, and high-protein meals in males. Ann Nutr Metab 50 (2006) 260-269
23. Nedvidkova J., Krykorkova I., Bartak V., et al. Loss of meal-induced decrease in plasma ghrelin levels in patients with anorexia nervosa. J Clin Endocrinol Metab 88 (2003) 1678-1682
24. Karhunen L., Flander S., Liukkonen K.H., Lähteenmäki L., Valtanen S., Jalkanen H., Uusitupa M., and Poutanen K. Fibre effectively inhibits postprandial decrease in plasma ghrelin concentration. Abstract Obes Rev 6 (2005) 59
25. Erdmann J., Lippl F., and Schusdziarra V. Differential effect of protein and fat on plasma ghrelin levels in man. Regul Pept 116 (2003) 101-107
26. Möhlig M., Koebnick C., Weickert M.O., et al. Arabinoxylan-enriched meal increases serum ghrelin levels in healthy humans. Horm Metab Res 37 (2005) 303-308
27. Weickert M.O., Spranger J., Holst J.J., Otto B., Koebnick C., Mohlig M., and Pfeiffer A.F. Wheat-fibre-induced changes of postprandial peptide YY and ghrelin responses are not associated with acute alterations of satiety. Br J Nutr 96 (2006) 795-798
28. Gruendel S., Garcia A.L., Otto B., Mueller C., Steiniger J., Weickert M.O., Speth M., Katz N., and Koebnick C. Carob pulp preparation rich in insoluble dietary fiber and polyphenols enhances lipid oxidation and lowers postprandial acylated ghrelin in humans. J Nutr 136 (2006) 1533-1538
29. Greenman Y., Golani N., Gilad S., Yaron M., Limor R., and Stern N. Ghrelin secretion is modulated in a nutrient- and gender-specific manner. Clin Endocrinol (Oxf) 60 (2004) 382-388
30. Erdmann J., Leibl M., Wagenpfeil S., Lippl F., and Schusdziarra V. Ghrelin response to protein and carbohydrate meals in relation to food intake and glycerol levels in obese subjects. Regul Pept 135 (2006) 23-29
31. Groschl M., Knerr I., Topf H.G., Schmid P., Rascher W., and Rauh M. Endocrine responses to the oral ingestion of a physiological dose of essential amino acids in humans. J Endocrinol 179 (2003) 237-244
32. Knerr I., Groschl M., Rascher W., and Rauh M. Endocrine effects of food intake: insulin, ghrelin, and leptin responses to a single bolus of essential amino acids in humans. Ann Nutr Metab 47 (2003) 312-318
33. Al-Awar R., Obeid O., Hwalla N., and Azar S. Postprandial acylated ghrelin status following fat and protein manipulation of meals in healthy young women. Clin Sci(Lond) 109 (2005) 405-411
34. Blom W.A., Lluch A., Stafleu A., et al. Effect of a high-protein breakfast on the postprandial ghrelin response. Am J Clin Nutr 83 (2006) 211-220
35. Bowen J., Noakes M., and Clifton P.M. Appetite regulatory hormone responses to various dietary proteins differ by body mass index status despite similar reductions in ad libitum energy intake. J Clin Endocrinol Metab 91 (2006) 2913-2919
36. Bowen J., Noakes M., Trenerry C., and Clifton P.M. Energy intake, ghrelin, and cholecystokinin after different carbohydrate and protein preloads in overweight men. J Clin Endocrinol Metab 91 (2006) 1477-1483
37. Aziz A. Anderson GH. The effects of dairy components on food intake and satiety. In: Saarela M. (Ed). Fuctional dairy products (2007), Woodhead Publishing Limited and CRC Press LLC, Cambridge 19-45
38. Lejeune M.P., Westerterp K.R., Adam T.C., Luscombe-Marsh N.D., and Westerterp-Plantenga M.S. Ghrelin and glucagon-like peptide 1 concentrations, 24-h satiety, and energy and substrate metabolism during a high-protein diet and measured in a respiration chamber. Am J Clin Nutr 83 (2006) 89-94
39. Möhlig M., Spranger J., Otto B., Ristow M., Tschop M., and Pfeiffer A.F. Euglycemic hyperinsulinemia, but not lipid infusion, decreases circulating ghrelin levels in humans. J Endocrinol Invest 25 (2002) RC36-RC38
40. Murray C.D., le Roux C.W., Gouveia C., et al. The effect of different macronutrient infusions on appetite, ghrelin and peptide YY in parenterally fed patients. Clin Nutr 25 (2006) 626-633
41. Erdmann J., Topsch R., Lippl F., Gussmann P., and Schusdziarra V. Postprandial response of plasma ghrelin levels to various test meals in relation to food intake, plasma insulin, and glucose. J Clin Endocrinol Metab 89 (2004) 3048-3054
42. Romon M., Gomila S., Hincker P., Soudan B., and Dallongeville J. Influence of weight loss on plasma ghrelin responses to high-fat and high-carbohydrate test meals in obese women. J Clin Endocrinol Metab 91 (2006) 1034-1041
43. Otto B., Heldwein W., Otto C., Huptas S., and Parhofer K.G. Effect of a high-fat meal on the postprandial ghrelin response. Am J Clin Nutr 84 (2006) 664-665
44. Feinle-Bisset C., Patterson M., Ghatei M.A., Bloom S.R., and Horowitz M. Fat digestion is required for suppression of ghrelin and stimulation of peptide YY and pancreatic polypeptide secretion by intraduodenal lipid. Am J Physiol Endocrinol Metab 289 (2005) E948-E953
45. Feltrin K.L., Patterson M., Ghatei M.A., Bloom S.R., Meyer J.H., Horowitz M., and Feinle-Bisset C. Effect of fatty acid chain length on suppression of ghrelin and stimulation of PYY, GLP-2 and PP secretion in healthy men. Peptides 27 (2006) 1638-1643
46. Degen L., Drewe J., Piccoli F., Gräni K., Oesch S., Bunea R., D'Amato M., and Beglinger C. Effect of CCK-1 receptor blockade on ghrelin and PYY secretion in men. Am J Physiol Regul Integr Comp Physiol 292 (2007) R1391-R1399
47. Liddle R.A. Cholecystokinin cells. Annu Rev Physiol 59 (1997) 221-242
48. Rehfeld J.F., and Hansen H.F. Characterization of preprocholecystokinin products in the porcine cerebral cortex. Evidence of different processing pathways. J Biol Chem 261 (1986) 5832-5840
49. Reeve Jr. J.R., Eysselein V., Walsh J.H., Ben-Avram C.M., and Shively J.E. New molecular forms of cholecystokinin. Microsequence analysis of forms previously characterized by chromatographic methods. J Biol Chem 261 (1986) 16392-16397
50. Rehfeld J.F., Sun G., Christensen T., and Hillingso J.G. The predominant cholecystokinin in human plasma and intestine is cholecystokinin-33. J Clin Endocrinol Metab 86 (2001) 251-258
51. Kopin A.S., Mathes W.F., McBride E.W., Nguyen M., Al-Haider W., Schmitz F., Bonner-Weir S., Kanarek R., and Beinborn M. The cholecystokinin-A receptor mediates inhibition of food intake yet is not essential for the maintenance of body weight. J Clin Invest 103 (1999) 383-391 Erratum in: J. Clin. Invest. 1999;103:759
52. Kissleff H.R., Pi-Sunyer F.X., Thompton J., and Smith G.P. C-terminal octapeptide of cholecystokinin decreases food intake in man. Am J Clin Nutr 34 (1981) 154-160
53. Lieverse R.J., Jansen J.B., Masclee A.A., and Lamers C.B. Satiety effects of a physiological dose of cholecystokinin in humans. Gut 36 (1995) 176-179
54. Kissileff H.R., Carretta J.C., Gelibter A., and Pi-Sunyer F.X. Cholecystokinin and stomach distension combine to reduce food intake in humans. Am J Physiol Regul Integr Comp Physiol 285 (2003) R992-R998
55. Moran T.H., and Kinzig K.P. Gastrointestinal satiety signals II. Cholecystokinin. Am J Physiol Gastrointest Liver Physiol 286 (2004) G183-G188
56. Hopman W.P., Jansen J.B., and Lamers C.B. Comparative study of the effects of equal amounts of fat, protein, and starch on plasma cholecystokinin in man. Scand J Gastroenterol 20 (1985) 843-847
57. Liddle R.A., Goldfine I.D., Rosen M.S., Taplitz R.A., and Williams J.A. Cholecystokinin bioactivity in human plasma. Molecular forms, responses to feeding, and relationship to gallbladder contraction. J Clin Invest 75 (1985) 1144-1152
58. Parker B.A., Doran S., Wishart J., Horowitz M., and Chapman I.M. Effects of small intestinal and gastric glucose administration on the suppression of plasma ghrelin concentrations in healthy older men and women. Clin Endocrinol (Oxf). 62 (2005) 539-546
59. Heini A.F., Lara-Castro C., Schneider H., Kirk K.A., Considine R.V., and Weinsier R.L. Effect of hydrolyzed guar fiber on fasting and postprandial satiety and satiety hormones: a double-blind, placebo-controlled trial during controlled weight loss. Int J Obes Relat Metab Disord 22 (1998) 906-909
60. Bourdon I., Yokoyama W., Davis P., Hudson C., Backus R., Richter D., Knuckles B., and Schneeman B.O. Postprandial lipid, glucose, insulin, and cholecystokinin responses in men fed barley pasta enriched with beta-glucan. Am J Clin Nutr 69 (1999) 55-63
61. Bourdon I., Olson B., Backus R., Richter B.D., Davis P.A., and Schneeman B.O. Beans, as a source of dietary fiber, increase cholecystokinin and apolipoprotein b48 response to test meals in men. J Nutr 131 (2001) 1485-1490
62. Hall W.L., Millward D.J., Long S.J., and Morgan L.M. Casein and whey exert different effects on plasma amino acid profiles, gastrointestinal hormone secretion and appetite. Br J Nutr 89 (2003) 239-248
63. Herzig K.H. Cholecystokinin- and secretin-releasing peptides in the intestine-a new regulatory interendocrine mechanism in the gastrointestinal tract. Regul Pept 73 (1998) 89-94
64. Pilichiewicz A.N., Little T.J., Brennan I.M., Meyer J.H., Wishart J.M., Otto B., Horowitz M., and Feinle-Bisset C. Effects of load, and duration, of duodenal lipid on antropyloroduodenal motility, plasma CCK and PYY, and energy intake in healthy men. Am J Physiol Regul Integr Comp Physiol 290 (2006) R668-R677
65. Feltrin K.L., Little T.J., Meyer J.H., Horowitz M., Rades T., Wishart J., and Feinle-Bisset C. Effects of lauric acid on upper gut motility, plasma cholecystokinin and peptide YY, and energy intake are load, but not concentration, dependent in humans. J Physiol 581 (2007) 767-777
66. Hopman W.P., Jansen J.B., Rosenbusch G., and Lamers C.B. Effect of equimolar amounts of long-chain triglycerides and medium-chain triglycerides on plasma cholecystokinin and gallbladder contraction. Am J Clin Nutr 39 (1984) 356-359
67. McLaughlin J., Grazia Lucà M., Jones M.N., D'Amato M., Dockray G.J., and Thompson D.G. Fatty acid chain length determines cholecystokinin secretion and effect on human gastric motility. Gastroenterology 116 (1999) 46-53
68. Matzinger D., Degen L., Drewe J., Meuli J., Duebendorfer R., Ruckstuhl N., D'Amato M., Rovati L., and Beglinger C. The role of long chain fatty acids in regulating food intake and cholecystokinin release in humans. Gut 46 (2000) 688-693
69. Feltrin K.L., Little T.J., Meyer J.H., Horowitz M., Smout A.J.P.M., Wishart J., Pilichiewicz A.N., Rades T., Chapman I.M., and Feinle-Bisset C. Effects of intraduodenal fatty acids on appetite, antropyloroduodenal motility, and plasma CCK and GLP-1 in humans vary with their chain length. Am J Physiol Regul Integr Comp Physiol 287 (2004) R524-R533
70. Robertson M.D., Henderson R.A., Vist G.E., and Rumsey R.D. Extended effects of evening meal carbohydrate-to-fat ratio on fasting and postprandial substrate metabolism. Am J Clin Nutr 75 (2002) 505-510
71. French S.J., Murray B., Rumsey R.D., Fadzlin R., and Read N.W. Adaptation to high-fat diets: effects on eating behaviour and plasma cholecystokinin. Br J Nutr 73 (1995) 179-189
72. Nauck M.A., Bartels E., Orskov C., Ebert R., and Creutzfeldt W. Additive insulinotropic effects of exogenous synthetic human gastric inhibitory polypeptide and glucagon-like peptide-1-(7-36) amide infused at near-physiological insulinotropic hormone and glucose concentrations. J Clin Endocrinol Metab 76 (1993) 912-917
73. Mortensen K., Christensen L.L., Holst J.J., and Orskov C. GLP-1 and GIP are colocalized in a subset of endocrine cells in the small intestine. Regul Pept 114 (2003) 189-196
74. Meier J.J., Nauck M.A., Schmidt W.E., and Gallwitz B. Gastric inhibitory polypeptide: the neglected incretin revisited. Regul Pept 107 (2002) 1-13
75. Vilsbøll T., Krarup T., Sonne J., Madsbad S., Volund A., Juul A.G., and Holst J.J. Incretin secretion in relation to meal size and body weight in healthy subjects and people with type 1 and type 2 diabetes mellitus. J Clin Endocrinol Metab 88 (2003) 2706-2713
76. Kieffer T.J., McIntosh C.H., and Pederson R.A. Degradation of glucose-dependent insulinotropic polypeptide and truncated glucagon-like peptide 1 in vitro and in vivo by dipeptidyl peptidase IV. Endocrinology 136 (1995) 3585-3596
77. Eckel R.H., Fujimoto W.Y., and Brunzell J.D. Gastric inhibitory polypeptide enhanced lipoprotein lipase activity in cultured preadipocytes. Diabetes 28 (1979) 1141-1142
78. Beck B., and Max J.P. Gastric inhibitory polypeptide enhancement of the insulin effect on fatty acid incorporation into adipose tissue in the rat. Regul Pept 7 (1983) 3-8
79. Meier J.J., Goetze O., Anstipp J., Hagemann D., Holst J.J., Schmidt W.E., Ballwitz B., and Nauck M.A. Gastric inhibitory polypeptide does not inhibit gastric emptying in humans. Am J Physiol Endocrinol Metab 286 (2004) E621-E625
80. Cataland S., Crockett S.E., Brown J.C., and Mazzaferri E.L. Gastric inhibitory polypeptide (GIP) stimulation by oral glucose in man. J Clin Endocrinol Metab 39 (1974) 223-228
81. Falko J.M., Crockett S.E., Cataland S.E., and Mazzaferri E.L. Gastric inhibitory polypeptide (GIP) stimulated by fat ingestion in man. J Clin Endocrinol Metab 41 (1975) 260-265
82. Sarson D.L., Bryant M.G., and Bloom S.R. A radioimmunoassay of gastric inhibitory polypeptide in human plasma. J Endocrinol 85 (1980) 487-496
83. Krarup T., Holst J.J., and Larsen K.L. Responses and molecular heterogeneity of IR-GIP after intraduodenal glucose and fat. Am J Physiol 249 (1985) E195-E200
84. Elliott R.M., Morgan L.M., Tredger J.A., Deacon S., Wright J., and Marks V. Glucagon-like peptide-1 (7-36) amide and glucose-dependent insulinotropic polypeptide secretion in response to nutrient ingestion in man: acute post-prandial and 24-h secretion patterns. J Endocrinol 138 (1993) 159-166
85. Herrmann C., Goke R., Richter G., Fehmann H.C., Arnold R., and Goke B. Glucagon-like peptide-1 and glucose-dependent insulin-releasing polypeptide plasma levels in response to nutrients. Digestion 56 (1995) 117-126
86. Thomas F.B., Mazzaferri E.L., Crockett S.E., Mekhjian H.S., Gruemer H.D., and Cataland S. Stimulation of secretion of gastric inhibitory polypeptide and insulin by intraduodenal amino acid perfusion. Gastroenterology 70 (1976) 523-527
87. Enc F.Y., Imeryüz N., Akin L., Turogly T., Dede F., Haklar G., Tekesin N., Bekiroglu N., Yegen B.C., Rehfeld J.F., Holst J.J., and Ulusoy N.B. Inhibition of gastric emptying by acarbose is correlated with GLP-1 response and accompanied by CCK release. Am J Physiol Gastrointest Liver Physiol 281 (2001) G752-G763
88. Vozzo R., Baker B., Wittert G.A., Wishart J.M., Morris H., Horowitz M., and Chapman I. Glycemic, hormone, and appetite responses to monosaccharide ingestion in patients with type 2 diabetes. Metabolism 51 (2002) 949-957
89. Thomsen C., Rasmussen O., Lousen T., Holst J.J., Fenselau S., Schrezenmeir J., and Hermansen K. Differential effects of saturated and monounsaturated fatty acids on postprandial lipemia and incretin responses in healthy subjects. Am J Clin Nutr 69 (1999) 1135-1143
90. Drucker D.J. The biology of incretin hormones. Cell Metab 3 (2006) 153-165
91. Wynne K., and Bloom S.R. The role of oxyntomodulin and peptide tyrosine-tyrosine (PYY) in appetite control. Nat Clin Pract Endocrinol Metab 2 (2006) 612-620
92. Feinle C., O'Donovan D., Doran S., Andrews J.M., Wishart J., Chapman I., and Horowitz M. Effects of fat digestion on appetite, APD motility, and gut hormones in response to duodenal fat infusion in humans. Am J Physiol Gastrointest Liver Physiol 284 (2003) G798-G807
93. Holst J.J. The physiology of glucagon-like peptide 1. Physiol Rev 87 (2007) 1409-1439
94. Nauck M.A., Niedereichholz U., Ettler R., Holst J.J., Orskov C., Ritzel R., and Schmiegel W.H. Glucagon-like peptide 1 inhibition of gastric emptying outweighs its insulinotropic effects in healthy humans. Am J Physiol 273 (1997) E981-E988
95. Orskov C., Holst J.J., and Nielsen O.V. Effect of truncated glucagon-like peptide-1 [proglucagon-(78-107) amide] on endocrine secretion from pig pancreas, antrum, and nonantral stomach. Endocrinology 123 (1988) 2009-2013
96. Farilla L., Hui H., Bertolotto C., Kang E., Bulotta A., Di Mario U., and Perfetti R. Glucagon-like peptide-1 promotes islet cell growth and inhibits apoptosis in Zucker diabetic rats. Endocrinology 143 (2002) 4397-4408
97. Brubaker P.L., and Anini Y. Direct and indirect mechanisms regulating secretion of glucagon-like peptide-1 and glucagon-like peptide-2. Can J Physiol Pharmacol 81 (2003) 1005-1012
98. Kong M.F., Chapman I., Goble I., Wishart J., Wittert G., Morris H., and Horowitz M. Effects of oral fructose and glucose on plasma GLP-1 and appetite in normal subjects. Peptides 20 (1999) 545-551
99. Adam T.C., and Westerterp-Plantenga M.S. Nutrient-stimulated GLP-1 release in normal-weight men and women. Horm Metab Res 37 (2005) 111-117
100. Raben A., Tagliabue A., Christensen N.J., Madsen J., Holst J.J., and Astrup A. Resistant starch: the effect on postprandial glycemia, hormonal response, and satiety. Am J Clin Nutr 60 (1994) 544-551
101. Juntunen K.S., Niskanen L.K., Liukkonen K.H., Poutanen K.S., Holst J.J., and Mykkanen H.M. Postprandial glucose, insulin, and incretin responses to grain products in healthy subjects. Am J Clin Nutr 75 (2002) 254-262
102. Frost G.S., Brynes A.E., Dhillo W.S., Bloom S.R., and McBurney M.I. The effects of fibre enrichment of pasta and fat content on gastric emptying, GLP-1, glucose, and insulin responses to a meal. Eur J Clin Nutr 57 (2003) 293-298
103. Raben A., Christensen N.J., Madsen J., Holst J.J., and Astrup A. Decreased postprandial thermogenesis and fat oxidation but increased fullness after a high-fiber meal compared with a low-fiber meal. Am J Clin Nutr 59 (1994) 1386-1394
104. Raben A., Agerholm-Larsen L., Flint A., Holst J.J., and Astrup A. Meals with similar energy densities but rich in protein, fat, carbohydrate, or alcohol have different effects on energy expenditure and substrate metabolism but not on appetite and energy intake. Am J Clin Nutr 77 (2003) 91-100
105. Brynes A.E., Frost G.S., Edwards C.M., Ghatei M.A., and Bloom S.R. Plasma glucagon-like peptide-1 (7-36) amide (GLP-1) response to liquid phase, solid phase, and meals of differing lipid composition. Nutrition 14 (1998) 433-436
106. Cox H.M. Peptide YY: a neuroendocrine neighbor of note. Peptides 28 (2007) 345-351
107. Adrian T.E., Ferri G.L., Bacarese-Hamilton A.J., Fuessl H.S., Polak J.M., and Bloom S.R. Human distribution and release of a putative new gut hormone, peptide YY. Gastroenterology 89 (1985) 1070-1077
108. Pironi L., Stanghellini V., Miglioli M., Corinaldesi R., De Giorgio R., Ruggeri E., Tosetti C., Poggioli G., Morselli Labate A.M., Monetti N., et al. Fat-induced ileal brake in humans: a dose-dependent phenomenon correlated to the plasma levels of peptide YY. Gastroenterology 105 (1993) 733-739
109. Boey D., Sainsbury A., and Herzog H. The role of peptide YY in regulating glucose homeostasis. Peptides 28 (2007) 390-395
110. Grandt D., Schimiczek M., Beglinger C., Layer P., Goebell H., Eysselein V.E., and Reeve Jr. J.R. Two molecular forms of peptide YY (PYY) are abundant in human blood: characterization of a radioimmunoassay recognizing PYY 1-36 and PYY 3-36. Regul Pept 51 (1994) 151-159
111. Chan J.L., Stoyneva V., Kelesidis T., Raciti P., and Mantzoros C.S. Peptide YY levels are decreased by fasting and elevated following caloric intake but are not regulated by leptin. Diabetologia 49 (2006) 169-173
112. Pedersen-Bjergaard U., Host U., Kelbaek H., Schifter S., Rehfeld J.F., Faber J., and Christensen N.J. Influence of meal composition on postprandial peripheral plasma concentrations of vasoactive peptides in man. Scand J Clin Lab Invest 56 (1996) 497-503
113. Soffer E.E., and Adrian T.E. Effect of meal composition and sham feeding on duodenojejunal motility in humans. Dig Dis Sci 37 (1992) 1009-1014
114. MacIntosh C.G., Andrews J.M., Jones K.L., Wishart J.M., Morris H.A., Jansen J.B.M.J., Morley J.E., Horowitz M., and Chapman I.M. Effects of age on concentrations of plasma cholecystokinin, glucagon-like peptide 1, and peptide YY and their relation to appetite and pyloric motility. Am J Clin Nutr 69 (1999) 999-1006
115. Essah P.A., Levy J.R., Sistrun S.N., Kelly S.M., and Nestler J.E. Effect of macronutrient composition on postprandial peptide YY levels. J Clin Endocrinol Metab 92 (2007) 4052-4055
116. Batterham R.L., Heffron H., Kapoor S., Chivers J.E., Chandarana K., Herzog H., Le Roux C.W., Thomas E.L., Bell J.D., and Withers D.J. Critical role for peptide YY in protein-mediated satiation and body-weight regulation. Cell Metab 4 (2006) 223-233
117. Maas M.I., Hopman W.P., Katan M.B., and Jansen J.B. Release of peptide YY and inhibition of gastric acid secretion by long-chain and medium-chain triglycerides but not by sucrose polyester in men. Eur J Clin Invest 28 (1998) 123-130
118. Serrano P., Yago M.D., Manas M.D., Calpena R., Mataix J., and Martinez-Victoria E. Influence of type of dietary fat (olive and sunflower oil) upon gastric acid secretion and release of gastrin, somatostatin, and peptide YY in man. Dig Dis Sci 42 (1997) 626-633
119. Calbet J.A., and Holst J.J. Gastric emptying, gastric secretion and enterogastrone response after administration of milk proteins or their peptide hydrolysates in humans. Eur J Nutr 43 (2004) 27-39
120. Sanggaard K.M., Holst J.J., Rehfeld J.F., Sandström B., Raben A., and Tholstrup T. Different effects of whole milk and a fermented milk with the same fat and lactose content on gastric emptying and postprandial lipaemia, but not on glycaemic response and appetite. Br J Nutr 92 (2004) 447-459
121. Weickert M.O., Reimann M., Otto B., Hall W.L., Vafeiadou K., Hallund J., Ferrari M., Talbot D., Branca F., Bügel S., Williams C.M., Zunft H.-J., and Koebnick C. Soy isoflavones increase preprandial peptide YY (PYY), but have no effect on ghrelin and body weight in healthy postmenopausal women. J Negat Results Biomed 5 (2006) 11
122. Porte D., Baskin D.G., and Schwartz M.W. Leptin and insulin action in the central nervous system. Nutr Rev 60 (2002) S20-S29
123. Newgard C.B., and Matschinsky F.M. Substrate control of insulin release. In: Jefferson L.S., Cherrington A.D., and Goodman H.M. (Eds). The endocrine pancreas and regulation of metabolism (2001), Oxford University Press, Oxford, New York 125-152
124. Newgard B.C., and McGarry J.D. Metabolic coupling factors in pancreatic-cell signal transduction. Annu Rev Biochem 64 (1995) 689-719
125. Henquin J., Dufrane D., and Nenquin M. Nutrient control of insulin secretion in isolated normal human islets. Diabetes 55 (2006) 3470-3477
126. Ullrich I.H., and Albrink M.J. The effect of dietary fiber and other factors on insulin response: role in obesity. J Environ Pathol Toxicol Oncol 5 (1985) 137-155
127. Jenkins D.J., Axelsen M., Kendall C.W., Augustin L.S., Vuksan V., and Smith U. Dietary fibre, lente carbohydrates and the insulin-resistant diseases. Br J Nutr 83 Suppl 1 (2000) S157-S163
128. Bessesen D.H. The role of carbohydrates in insulin resistance. J Nutr 131 (2001) 2782S-2786S
129. Erkkilä A.T., and Lichtenstein A.H. Fiber and cardiovascular disease risk: how strong is the evidence?. J Cardiovasc Nurs 21 (2006) 3-8
130. Ludwig D.S., Pereira M.A., Kroenke C.H., Hilner J.E., Van Horn L., Slattery M.L., and Jacobs D.R. Dietary fiber, weight gain, and cardiovascular disease risk factors in young adults. JAMA 27 282 (1999) 1539-1546
131. Wolever T.M. Dietary carbohydrates and insulin action in humans. Br J Nutr 83 Suppl 1 (2000) S97-S102
132. von Post-Skagegård M., Vessby B., and Karlström B. Glucose and insulin responses in healthy women after intake of composite meals containing cod-, milk-, and soy protein. Eur J Clin Nutr 60 (2006) 949-954
133. Dangin M., Boirie Y., Garcia -Rodenas C., Gachon P., Fauquant J., Callier R., Ballevre O., and Beaufrére B. The digestion rate of protein is an independent regulating factor of postprandial protein retention. Am J Physiol 280 (2001) E340-E348
134. Nilsson M., Holst J.J., and Bjorck I.M. Metabolic effects of amino acid mixtures and whey protein in healthy subjects: studies using glucose-equivalent drinks. Am J Clin Nutr 85 (2007) 996-1004
135. Floyd Jr. J.C., Fajans S.S., Conn J.W., Knopf R.F., and Rull J. Stimulation of insulin secretion by amino acids. J Clin Invest 45 (1966) 1487-1502
136. Nilsson M., Stenberg M., Frid A.H., Holst J.J., and Björck I.M. Glycemia and insulinemia in healthy subjects after lactose-equivalent meals of milk and other food proteins: the role of plasma amino acids and incretins. Am J Clin Nutr 80 (2004) 1246-1253
137. Ishiyama N., Ravier M.A., and Henquin J.C. Dual mechanism of the potentiation by glucose of insulin secretion induced by arginine and tolbutamide in mouse islets. Am J Physiol Endocrinol Metab 290 (2006) E540-E549
138. Copinschi G., Wegienka L.C., Hane S., and Forsham P.H. Effect of arginine on serum levels of insulin and growth hormone in obese subjects. Metabolism 16 (1967) 485-491
139. Palmer J., Walter R., and Ensinck J. Arginine-stimulated acute phase of insulin and glucagon secretion. I. in normal man. Diabetes 24 (1975) 735-740
140. Gannon M.C., Nuttall J.A., and Nuttall F.Q. Oral arginine does not stimulate an increase in insulin concentration but delays glucose disposal. Am J Clin Nutr 76 (2002) 1016-1022
141. Stein D.T., Esser V., Stevenson B.E., Lane K.E., Whiteside J.H., Daniels M.B., et al. Essentiality of circulating fatty acids for glucose-stimulated insulin secretion in the fasted rat. J Clin Invest 97 (1996) 2728-2735
142. Stein D.T., Stevenson B.E., Chester M.W., Basit M., Daniels M.B., Turley S.D., et al. The insulinotropic potency of fatty acids is influenced profoundly by their chain length and degree of saturation. J Clin Invest 100 (1997) 398-403
143. McGarry J.D. Banting lecture 2001: dysregulation of fatty acid metabolism in the etiology of type 2 diabetes. Diabetes 51 (2002) 7-18
144. Prentki M., Joly E., El-Assaad W., and Roduit R. Malonyl-CoA signaling, lipid partitioning, and glucolipotoxicity: role in {beta}-cell adaptation and failure in the etiology of diabetes. Diabetes 51 (2002) S405-S413
145. Kahn S.E., Hull R.L., and Utzschneider K.M. Mechanisms linking obesity to insulin resistance and type 2 diabetes. Nature 444 (2006) 840-846
146. Cooper G.J.S., Willis A.C., Clark A., Turner R.C., Sim R.B., and Reid K.B.M. Purification and characterization of a peptide from amyloid-rich pancreases of type 2 diabetic patients. Proc Natl Acad Sci USA 84 (1987) 8628-8632
147. Lutz T.A., Geary N., Szabady M.M., Del Prete E., and Scharrer E. Amylin decreases meal size in rats. Physiol Behav 58 (1995) 1197-1202
148. Lutz T.A. Amylinergic control of food intake. Physiol Behav 30 89 (2006) 465-471
149. Reda T.K., Geliebter A., and Pi-Sunyer F.X. Amylin, food intake, and obesity. Obesity Res 10 (2002) 1087-1091
150. Cooper G.J.S. Amylin and related proteins: physiology and pathophysiology. In: Jefferson L.S., Cherrington A.D., and Goodman H.M. (Eds). The endocrine pancreas and regulation of metabolism (2001), Oxford University Press, Inc, Oxford, New York 303-396
151. Moore C.X., and Cooper G.J. Co-secretion of amylin and insulin from cultured islet beta-cells: modulation by nutrient secretagogues, islet hormones and hypoglycemic agents. Biochem Biophys Res Commun 179 (1991) 1-9
152. Mitsukawa T., Takemura J., Asai J., Nakazato M., Kangawa K., Matsuo H., and Matsukura S. Islet amyloid polypeptide response to glucose, insulin, and somatostatin analogue administration. Diabetes 39 (1990) 639-642
153. van Hulst K.L., Nieuwenhuis M.G., Höppener J.W., Lips C.J., and Blankenstein M.A. Lack of islet amyloid polypeptide/amylin-immunoreactivity in urine collected from healthy volunteers after ingestion of a carbohydrate-rich meal. Exp Clin Endocrinol Diabetes 104 (1996) 177-179
154. Butler P.C., Chou J., Carter W.B., Wang Y.N., Bu B.H., Chang D., Chang J.K., and Rizza R.A. Effects of meal ingestion on plasma amylin concentration in NIDDM and nondiabetic humans. Diabetes 39 (1990) 752-756
155. Heptulla R.A., Rodriguez L.M., Bomgaars L., and Haymond M.W. The role of amylin and glucagon in the dampening of glycemic excursions in children with type 1 diabetes. Diabetes 54 (2005) 1100-1107
156. Poppitt S.D., Keogh G.F., Mulvey T.B., Phillips A., McArdle B.H., MacGibbon A.K., and Cooper G.J. Effect of moderate changes in dietary fatty acid profile on postprandial lipaemia, haemostatic and related CVD risk factors in healthy men. Eur J Clin Nutr 58 (2004) 819-827
157. Taborsky G.J.J. Insulin and glucagon secretion in vivo and its neural control. In: Jefferson L.S., Cherrington A.D., and Goodman H.M. (Eds). Handbook of physiology. Section 7 The Endocrine System (2001), Oxfrord University Press, Inc, Oxford, New York 153-176
158. Wynne K., Stanley S., and Bloom S. The gut and regulation of body weight. J Clin Endocrinol Metab 89 (2004) 2576-2582
159. Rossi J., Santamaki P., Airaksinen M.S., and Herzig K. Parasympathetic innervation and function of endocrine pancreas requires the glial cell line-derived factor family receptor α2 (GFRα2). Diabetes 54 (2005) 1324-1330
160. Schwartz T.W. Pancreatic polypeptdide: a unique model for vagal control of endocrine systems. J Auton Nerv Syst 9 (1983) 99-111
161. Okita M., Inui A., Baba S., and Kasuga M. Central cholinergic regulation of pancreatic polypeptide secretion in conscious dogs. J Endocrinol 154 (1997) 311-317
162. Kojima S., Ueno N., Asakawa A., Sagiyama K., Naruo T., Mizuno S., et al. A role for pancreatic polypeptide in feeding and body weight regulation. Peptides 28 (2007) 459-463
163. Katsuura G., Asakawa A., and Inui A. Roles of pancreatic polypeptide in regulation of food intake. Peptides 23 (2002) 323-329
164. Jesudason D.R., Monteiro M.P., McGowan B.M., Neary N.M., Park A.J., Philippou E., Small C.J., Frost G.S., Ghatei M.A., and Bloom S.R. Low-dose pancreatic polypeptide inhibits food intake in man. Br J Nutr 97 (2007) 426-429
165. Adrian T.E., Besterman H.S., Cooke T.J., Bloom S.R., Barnes A.J., and Russell R.C. Mechanism of pancreatic polypeptide release in man. Lancet 22 1 (1977) 161-163
166. Batterham R.L., Le Roux C.W., Cohen M.A., Park A.J., Ellis S.M., Patterson M., Frost G.S., Ghatei M.A., and Bloom S.R. Pancreatic polypeptide reduces appetite and food intake in humans. J Clin Endocrinol Metab 88 (2003) 3989-3992
167. Witteman B.J., Edwards-Teunissen K., Hopman W.P., Jebbink M.C., Masclee A.A., Lamers C.B., and Jansen J.B. Nutrient-specific effects of modified sham feeding on pancreatic polypeptide release. Eur J Clin Nutr 48 (1994) 556-560
168. Robertson M.D., Mason A.O., and Frayn K.N. Timing of vagal stimulation affects postprandial lipid metabolism in humans. Am J Clin Nutr 76 (2002) 71-77
169. Simonian H.P., Kresge K.M., Boden G.H., and Parkman H.P. Differential effects of sham feeding and meal ingestion on ghrelin and pancreatic polypeptide levels: evidence for vagal efferent stimulation mediating ghrelin release. Neurogastroenterol Motil 17 (2005) 348-354
170. Crystal S.R., and Teff K.L. Tasting fat: cephalic phase hormonal responses and food intake in restrained and unrestrained eaters. Physiol Behav 30 89 (2006) 213-220
171. Tasaka Y., Inoue S., Maruno K., and Hirata Y. Twenty-four-hour variations of plasma pancreatic polypeptide, insulin and glucagon in normal human subjects. Endocrinol Jpn 27 (1980) 495-498
172. Holmbäck U., Forslund A., Lowden A., Forslund J., Akerstedt T., Lennernäs M., Hambraeus L., and Stridsberg M. Endocrine responses to nocturnal eating-possible implications for night work. Eur J Nutr 42 (2003) 75-83
173. Sive A.A., Vinik A.I., and van Tonder S.V. Pancreatic polypeptide (PP) responses to oral and intravenous glucose in man. Am J Gastroenterol 71 (1979) 183-185
174. Taylor I.L., Gulsrud P.O., Elashoff J., Chew P., and Meyer J.H. Gastric emptying and pancreatic polypeptide response to carbohydrate meals. Dig Dis Sci 30 (1985) 52-57
175. Layer P., Go V.L., and DiMagno E.P. Carbohydrate digestion and release of pancreatic polypeptide in health and diabetes mellitus. Gut 30 (1989) 1279-1284
176. Waldhäusl W.K., Gasić S., Bratusch-Marrain P., and Nowotny P. The 75-g oral glucose tolerance test: effect on splanchnic metabolism of substrates and pancreatic hormone release in healthy man. Diabetologia 25 (1983) 489-495
177. Schwartz S.E., Levine R.A., Weinstock R.S., Petokas S., Mills C.A., and Thomas F.D. Sustained pectin ingestion: effect on gastric emptying and glucose tolerance in non-insulin-dependent diabetic patients. Am J Clin Nutr 48 (1988) 1413-1417
178. Schwartz S.E., Levine R.A., Singh A., Scheidecker J.R., and Track N.S. Sustained pectin ingestion delays gastric emptying. Gastroenterology 83 (1982) 812-817
179. Fuessl H.S., Williams G., Adrian T.E., and Bloom S.R. Guar sprinkled on food: effect on glycaemic control, plasma lipids and gut hormones in non-insulin dependent diabetic patients. Diabet Med 4 (1987) 463-468
180. Trinick T.R., Laker M.F., Johnston D.G., Keir M., Buchanan K.D., and Alberti K.G. Effect of guar on second-meal glucose tolerance in normal man. Clin Sci (Lond) 71 (1986) 49-55
181. Di Lorenzo C., Williams C.M., Hajnal F., and Valenzuela J.E. Pectin delays gastric emptying and increases satiety in obese subjects. Gastroenterology 95 (1988) 1211-1215
182. Tsai A.C., Vinik A.I., Lasichak A., and Lo G.S. Effects of soy polysaccharide on postprandial plasma glucose, insulin, glucagon, pancreatic polypeptide, somatostatin, and triglyceride in obese diabetic patients. Am J Clin Nutr 45 (1987) 596-601
183. Schmid R., Schusdziarra V., Schulte-Frohlinde E., Maier V., and Classen M. Role of amino acids in stimulation of postprandial insulin, glucagon, and pancreatic polypeptide in humans. Pancreas 4 (1989) 305-314
184. Schmid R., Schulte-Frohlinde E., Schusdziarra V., Neubauer J., Stegmann M., Maier V., and Classen M. Contribution of postprandial amino acid levels to stimulation of insulin, glucagon, and pancreatic polypeptide in humans. Pancreas 7 (1992) 698-704
185. Zipf W.B., O'Dorisio T.M., Cataland S., and Dixon K. Pancreatic polypeptide responses to protein meal challenges in obese but otherwise normal children and obese children with Prader-Willi syndrome. J Clin Endocrinol Metab 57 (1983) 1074-1080
186. Lawson M., Everson G.T., Klingensmith W., and Kern F. Coordination of gastric and gallbladder emptying after ingestion of a regular meal. Gastroenterology 85 (1983) 866-870
187. Robertson M.D., Henderson R.A., Vist G.E., and Rumsey R.D. Plasma ghrelin response following a period of acute overfeeding in normal weight men. Int J Obes Relat Metab Disord 28 (2004) 727-733